Therefore, induction of ERRFI1 expression, in response to GR activation by HNK, could be a strategy for HCC prevention in patients with chronic liver diseases, particularly those with NAFLD [73]. The gene discussed is ERRFI1; the disease is hepatocellular carcinoma.